Clinical Trials Directory

Trials / Completed

CompletedNCT00131729

Electronic Recording of Compliance With Occlusion Therapy for Amblyopia

Electronic Recording of Compliance With Occlusion Therapy for Amblyopia: 1 Effects of Patient Education on Compliance 2 Predictors for Non-Compliance

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
200 (planned)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
0 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to determine whether compliance with occlusion therapy for amblyopia could be improved and, secondly, if risk factors for non-compliance could be identified.

Detailed description

Non-compliance is a limiting factor for success of occlusion therapy for amblyopia (lazy eye) in childhood. It is responsible for approximately 1% of the adult population being unable to read with the amblyopic eye. The researchers used electronic monitoring of compliance to investigate predictors and a remedy for non-compliance. Methods: In a prospective randomised controlled trial, compliance was measured for one week every three months during 30 months in newly diagnosed amblyopic children in The Hague, Frankfurt and Leicester. The family's social-economic and ethnic background was assessed through a questionnaire. Children were randomised to receive either an educational cartoon story explaining, without text, the rationale for treatment to the child with reward stickers and an information sheet, or a picture to colour. All received standard orthoptic care by a treating orthoptist, who was unaware of the randomisation. The electronic device and educational programme were distributed via home-visits by researchers. The primary outcome measure was percentage of compliance (realised/prescribed occlusion time). The secondary outcome measure was influence of social-economic, ethnic and clinical factors on compliance.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEducational programme

Timeline

Start date
2001-07-01
Completion
2005-12-01
First posted
2005-08-19
Last updated
2006-03-20

Locations

2 sites across 2 countries: Germany, United Kingdom

Source: ClinicalTrials.gov record NCT00131729. Inclusion in this directory is not an endorsement.